Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
CordenPharma Invests >€1 billion to Expand its Greenfield Facility
CordenPharma has announced plans to invest more than 1 billion over the next three years to build and expand peptide manufacturing facilities across Europe and the United States
Axplora Invests €50 Million in Mourenx Site Construction
Axplora, a global leader in API small molecule and ADC manufacturing, has announced a 50 million investment in its Mourenx facility in southwest France This development aims to strengthen its role in addressing cardiovascular and metabolic diseases
Orano Med Invests €250 Million in New Facility for Lead-212 Radioligand Therapy Precursors
Orano Med, part of the Orano Group and a leader in the development of targeted alpha therapies for cancer treatment, has marked the groundbreaking of its Advanced Thorium Extraction Facility ATEF in France
Novo Nordisk Commits 8.5 Billion to Build New Production Facility in Denmark
Novo Nordisk has revealed plans to invest 85 billion Danish kroner in the construction of a new production facility in Denmark This marks the first time in this century that the company has launched a new production site in Denmark
Ardena Invests €20 million for the Expansion of New Nanomedicine Facility in Netherlands
Ardena has invested 20 million in expanding its nanomedicine manufacturing facility in the Netherlands, achieving full Good Manufacturing Practice GMP certification
Merck Invests €70 Million to Expand ADC Manufacturing for Cancer Therapies in the U.S.
Merck Company has announced 70 million to expand its ADC manufacturing capabilities in the USA This expansion will significantly increase capacity, tripling the current levels, and strengthen the companys contract development and manufacturing organization
Piramal Pharma Invests $80 Million to Expand Sterile Injectable Facility in Kentucky
Piramal Pharma Solutions PPS is investing $80M to expand its Lexington, Kentucky facility This site specializes in sterile injectable drug products, including compounding, liquid filling, and lyophilization The expansion will support PPSs ADCelerate
AstraZeneca Invests $3.5 Billion to Expand R&D and Manufacturing in the U.S
AstraZeneca has unveiled plans for a $35 billion capital investment in the United States to enhance its research and manufacturing capabilities This initiative includes $2 billion allocated to new projects, which are set to generate over a thousand highskilled jobs, bolstering
Thermo Fisher Scientific to Expand Kentucky Clinical Research Facility with $47.8 Million Investment
Thermo Fisher Scientific Incs PPD clinical research business is embarking on a significant expansion of its central laboratory operations in Kentucky
Novo Nordisk to Invest $4.1 Billion in Expanding US Manufacturing Capacity
Novo Nordisk has announced a $41 billion USD approximately 27 billion Danish kroner investment to build a new fill and finishing manufacturing facility in Clayton, North Carolina
